Shoukat Afshar-Sterle

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Induced Apoptosis

Histone Deacetylase

Top Venues

Science signaling

Molecular cancer therapeutics

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Shoukat Afshar-Sterle, Annalisa L E Carli, Ryan N O'Keefe, Janson Tse, Stefanie Fischer, Alexander I Azimpour, David Baloyan, Lena Elias, Pathum Thilakasiri, Onisha Patel, Fleur M Ferguson, Moritz F Eissmann, Ashwini L Chand, Nathanael S Gray, Rita A Busuttil, Alex Boussioutas, Isabelle S Lucet, Matthias Ernst, Michael Buchert
DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progression. Science signaling 17 (854) (2024)
Marina H Yakou, Sonia Ghilas, Kelly Tran, Yang Liao, Shoukat Afshar-Sterle, Anita Kumari, Kevin Schmid, Christine Dijkstra, Chantelle Inguanti, Simone Ostrouska, Jordan Wilcox, Maxine Smith, Pavitha Parathan, Amr Allam, Hai-Hui Xue, Gabrielle T Belz, John M Mariadason, Andreas Behren, Grant R Drummond, Roland Ruscher, David S Williams, Bhupinder Pal, Wei Shi, Matthias Ernst, Dinesh Raghu, Lisa A Mielke
TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma. Science immunology 8 (88) (2023)
Laura J Jenkins, Ian Y Luk, Walter Douglas Fairlie, Erinna F Lee, Michelle Palmieri, Kael L Schoffer, Tao Tan, Irvin Ng, Natalia Vukelic, Sharon Tran, Janson Wt Tse, Rebecca Nightingale, Zakia Alam, Fiona Chionh, George Iatropoulos, Matthias Ernst, Shoukat Afshar-Sterle, Jayesh Desai, Peter Gibbs, Oliver M Sieber, Amardeep S Dhillon, Niall C Tebbutt, John M Mariadason
Genotype-tailored ERK/MAPK pathway and HDAC inhibition rewires the apoptotic rheostat to trigger colorectal cancer cell death. Molecular cancer therapeutics (2022)